Hepatitis B

• FDA label_change · 2019-11-06
  FDA Approved: BARACLUDE — Supplemental Application (E.R. Squibb & Sons, L.L.C.)

  FDA approved a supplemental application for BARACLUDE (entecavir) submitted by E.R. Squibb & Sons to update the drug’s labeling.

• FDA label_change · 2012-10-12
  FDA Approved: BARACLUDE — Supplemental Application (E.R. Squibb & Sons, L.L.C.)

  The FDA approved a supplemental application for Baraclude (entecavir) submitted by E.R. Squibb & Sons, L.L.C., to modify labeling following …

• FDA label_change · 2009-07-16
  FDA Approved: BARACLUDE — Supplemental Application (E.R. Squibb & Sons, L.L.C.)

  The FDA approved a supplemental application for Baraclude (entecavir) by E.R. Squibb & Sons, L.L.C. This action updates the labeling for chr…

• FDA label_change · 2009-07-16
  FDA Approved: BARACLUDE — Supplemental Application (E.R. Squibb & Sons, L.L.C.)

  FDA approved a supplemental application for BARACLUDE (entecavir) submitted by E.R. Squibb & Sons, L.L.C., reflecting an update to the produ…

• FDA label_change · 2008-07-25
  FDA Approved: BARACLUDE — Supplemental Application (E.R. Squibb & Sons, L.L.C.)

  FDA documents a supplemental application for BARACLUDE (entecavir) submitted by E.R. Squibb & Sons, L.L.C., indicating a proposed update to …

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA label_change · 2007-02-23
  FDA Approved: BARACLUDE — Supplemental Application (E.R. Squibb & Sons, L.L.C.)

  FDA approved a supplemental application for Baraclude (entecavir) filed by E.R. Squibb & Sons, L.L.C., related to labeling changes.